Paratek Pharmaceuticals Presenting New Data from NUZYRA and Investigator-Initiated Research Programs at ASM Microbe 2023

PRTKDelisted Stock  USD 2.18  0.00  0.00%   
About 56% of Paratek Pharmaceuticals' investor base is looking to short. The analysis of current outlook of investing in Paratek Pharmaceuticals suggests that many traders are alarmed regarding Paratek Pharmaceuticals' prospects. Paratek Pharmaceuticals' investing sentiment shows overall attitude of investors towards Paratek Pharmaceuticals.
  
BOSTON, June 12, 2023 Paratek Pharmaceuticals, Inc. , a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for

Read at benzinga.com
benzinga news
  

Paratek Pharmaceuticals Fundamental Analysis

We analyze Paratek Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Paratek Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Paratek Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Price To Sales

Price To Sales Comparative Analysis

Paratek Pharmaceuticals is currently under evaluation in price to sales category among its peers. Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

Paratek Pharmaceuticals Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Paratek Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Paratek Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Paratek Pharmaceuticals by comparing valuation metrics with similar companies.

Peers

Paratek Pharmaceuticals Related Equities

LYRALyra Therapeutics   10.53   
0%
100.0%
APTOAptose Biosciences   5.56   
0%
52.0%
EQEquillium   1.41   
0%
13.0%
AFMDAffimed NV   0.40   
3.0%
0%
JSPRJasper Therapeutics   2.24   
21.0%
0%
HOOKHookipa Pharma   2.75   
26.0%
0%
ADAPAdaptimmune Therapeutics   2.78   
26.0%
0%
CRVSCorvus Pharmaceuticals   3.02   
28.0%
0%
IMMPImmutep   3.47   
32.0%
0%
LPTXLeap Therapeutics   3.79   
35.0%
0%
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Consideration for investing in Paratek Stock

If you are still planning to invest in Paratek Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Paratek Pharmaceuticals' history and understand the potential risks before investing.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities